Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John N Weinstein

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Molecular Cancer Therapeutics|November 8, 2006
Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell linesJohn N Weinstein
Breast Disease|February 3, 2005
Integromic analysis of the NCI-60 cancer cell linesJohn N Weinstein
Nature|March 31, 2012
Drug discovery: Cell lines battle cancerJohn N Weinstein
Molecular Cancer Therapeutics|November 11, 2011
MicroRNAs in cancer pharmacology and therapeutics: exploiting a natural synergy between '-omic' and hypothesis-driven researchJohn N Weinstein
Science (New York, N.Y.)|March 29, 2008
Biochemistry. A postgenomic visual iconJohn N Weinstein
Current Opinion in Pharmacology|July 20, 2002
'Omic' and hypothesis-driven research in the molecular pharmacology of cancerJohn N Weinstein
Nature Biotechnology|November 10, 2006
Connecting genes, drugs and diseasesJohn N Weinstein, Yves Pommier
Comptes Rendus Biologies|January 28, 2004
Transcriptomic analysis of the NCI-60 cancer cell linesJohn N Weinstein, Yves Pommier
BMC Bioinformatics|July 5, 2005
Quality assessment of microarrays: visualization of spatial artifacts and quantitation of regional biasesMark Reimers, John N Weinstein
Drug News & Perspectives|February 12, 2009
Asparagine synthetase: a new potential biomarker in ovarian cancerPhilip L Lorenzi, John N Weinstein
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Molecular Cancer Therapeutics|November 8, 2006
Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell linesJohn N Weinstein
Breast Disease|February 3, 2005
Integromic analysis of the NCI-60 cancer cell linesJohn N Weinstein
Nature|March 31, 2012
Drug discovery: Cell lines battle cancerJohn N Weinstein
Molecular Cancer Therapeutics|November 11, 2011
MicroRNAs in cancer pharmacology and therapeutics: exploiting a natural synergy between '-omic' and hypothesis-driven researchJohn N Weinstein
Science (New York, N.Y.)|March 29, 2008
Biochemistry. A postgenomic visual iconJohn N Weinstein
Current Opinion in Pharmacology|July 20, 2002
'Omic' and hypothesis-driven research in the molecular pharmacology of cancerJohn N Weinstein
Nature Biotechnology|November 10, 2006
Connecting genes, drugs and diseasesJohn N Weinstein, Yves Pommier
Comptes Rendus Biologies|January 28, 2004
Transcriptomic analysis of the NCI-60 cancer cell linesJohn N Weinstein, Yves Pommier
BMC Bioinformatics|July 5, 2005
Quality assessment of microarrays: visualization of spatial artifacts and quantitation of regional biasesMark Reimers, John N Weinstein
Drug News & Perspectives|February 12, 2009
Asparagine synthetase: a new potential biomarker in ovarian cancerPhilip L Lorenzi, John N Weinstein
Pageof 21